Literature DB >> 18498870

Activation of peroxisome proliferator-activated receptor-gamma during hepatic ischemia is age-dependent.

Thomas Shin1, Satoshi Kuboki, Nadine Huber, Thorsten Eismann, Elizabeth Galloway, Rebecca Schuster, John Blanchard, Timothy A Pritts, Alex B Lentsch.   

Abstract

Hepatic ischemia/reperfusion injury is a complication of liver surgery, transplantation, and shock and is known to be age-dependent. Our laboratory has recently shown that peroxisome proliferator-activated receptor-gamma (PPARgamma) is down-regulated during hepatic ischemia and that this exacerbates injury. Here we examined whether activation of PPARgamma during ischemia was age-dependent. Male mice of different ages (young: 4-5 weeks; adult: 10-12 weeks; old: 10-12 months) were subjected to up to 90 min of hepatic ischemia. PPARgamma activation occurred throughout ischemia in young mice, whereas activation in adult and old mice was lost after 30 min. No significant differences were noted in PPARgamma ligand expression among the age groups. However, in young mice we observed a predominance of PPARgamma1 in the nucleus, whereas in old mice this isoform remained largely in the cytoplasm. Finally, the degree of PPARgamma activation was associated with autophagy in the liver, a mechanism of self-preservation. PPARgamma activation is prolonged in young mice as compared to older mice. This appears to be mediated by a selective retention of PPARgamma1 in the nucleus and is associated with increased autophagy. The data suggest that PPARgamma activation is an important component of the age-dependent response to hepatic ischemia/reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18498870      PMCID: PMC2737330          DOI: 10.1016/j.jss.2008.02.004

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

Review 1.  Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury.

Authors:  A B Lentsch; A Kato; H Yoshidome; K M McMasters; M J Edwards
Journal:  Hepatology       Date:  2000-08       Impact factor: 17.425

Review 2.  Autophagy: molecular machinery for self-eating.

Authors:  T Yorimitsu; D J Klionsky
Journal:  Cell Death Differ       Date:  2005-11       Impact factor: 15.828

Review 3.  Autophagy in cell death: an innocent convict?

Authors:  Beth Levine; Junying Yuan
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

Review 4.  The role of autophagy in mediating cell survival and death during ischemia and reperfusion in the heart.

Authors:  Hiromitsu Takagi; Yutaka Matsui; Junichi Sadoshima
Journal:  Antioxid Redox Signal       Date:  2007-09       Impact factor: 8.401

5.  The injured child is resistant to multiple organ failure: a different inflammatory response?

Authors:  Casey M Calkins; Denis D Bensard; Ernest E Moore; Robert C McIntyre; Christopher C Silliman; Walter Biffl; Alden H Harken; David A Partrick; Patrick J Offner
Journal:  J Trauma       Date:  2002-12

6.  Age-dependent responses to hepatic ischemia/reperfusion injury.

Authors:  Tomohisa Okaya; John Blanchard; Rebecca Schuster; Satoshi Kuboki; Thomas Husted; Charles C Caldwell; Basilia Zingarelli; Hector Wong; Joseph S Solomkin; Alex B Lentsch
Journal:  Shock       Date:  2005-11       Impact factor: 3.454

7.  Preoperative factors associated with outcome and their impact on resource use in 1148 consecutive primary liver transplants.

Authors:  J F Markmann; J W Markmann; D A Markmann; A Bacquerizo; J Singer; C D Holt; J Gornbein; H Yersiz; M Morrissey; S M Lerner; S V McDiarmid; R W Busuttil
Journal:  Transplantation       Date:  2001-09-27       Impact factor: 4.939

8.  Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy.

Authors:  Yutaka Matsui; Hiromitsu Takagi; Xueping Qu; Maha Abdellatif; Hideyuki Sakoda; Tomoichiro Asano; Beth Levine; Junichi Sadoshima
Journal:  Circ Res       Date:  2007-03-01       Impact factor: 17.367

9.  Importance of peroxisome proliferator-activated receptor-gamma in hepatic ischemia/reperfusion injury in mice.

Authors:  Takahiro Akahori; Masayuki Sho; Kaoru Hamada; Yasue Suzaki; Yukiyasu Kuzumoto; Takeo Nomi; Shinji Nakamura; Koji Enomoto; Hiromichi Kanehiro; Yoshiyuki Nakajima
Journal:  J Hepatol       Date:  2007-10-04       Impact factor: 25.083

10.  Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice.

Authors:  Satoshi Kuboki; Thomas Shin; Nadine Huber; Thorsten Eismann; Elizabeth Galloway; Rebecca Schuster; John Blanchard; Basilia Zingarelli; Alex B Lentsch
Journal:  Hepatology       Date:  2008-01       Impact factor: 17.425

View more
  21 in total

Review 1.  Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms.

Authors:  Wasim A Dar; Elise Sullivan; John S Bynon; Holger Eltzschig; Cynthia Ju
Journal:  Liver Int       Date:  2019-04-02       Impact factor: 5.828

2.  The effects of glutamine on hepatic ischemia reperfusion injury in rats.

Authors:  S Sözen; M Kisakürek; F Yildiz; M Gönültaş; A S Dinçel
Journal:  Hippokratia       Date:  2011-04       Impact factor: 0.471

3.  Milk fat globule--EGF factor VIII ameliorates liver injury after hepatic ischemia-reperfusion.

Authors:  Akihisa Matsuda; Asha Jacob; Rongqian Wu; Mian Zhou; Monowar Aziz; Ping Wang
Journal:  J Surg Res       Date:  2012-03-31       Impact factor: 2.192

4.  Gestational exercise protects adult male offspring from high-fat diet-induced hepatic steatosis.

Authors:  Ryan D Sheldon; A Nicole Blaize; Justin A Fletcher; Kevin J Pearson; Shawn S Donkin; Sean C Newcomer; R Scott Rector
Journal:  J Hepatol       Date:  2015-08-29       Impact factor: 25.083

5.  Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor-gamma in hemorrhagic shock.

Authors:  Basilia Zingarelli; Ranjit Chima; Michael O'Connor; Giovanna Piraino; Alvin Denenberg; Paul W Hake
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-19       Impact factor: 4.052

6.  Resveratrol attenuates oxidative stress and histological alterations induced by liver ischemia/reperfusion in rats.

Authors:  Ercan Gedik; Sadullah Girgin; Hayrettin Ozturk; Basra-Deniz Obay; Hulya Ozturk; Huseyin Buyukbayram
Journal:  World J Gastroenterol       Date:  2008-12-14       Impact factor: 5.742

Review 7.  The controversy over H5N1 transmissibility research: an opportunity to define a practical response to a global threat.

Authors:  David S Fedson; Steven M Opal
Journal:  Hum Vaccin Immunother       Date:  2013-02-07       Impact factor: 3.452

8.  Clinician-initiated research on treating the host response to pandemic influenza.

Authors:  David S Fedson
Journal:  Hum Vaccin Immunother       Date:  2017-10-31       Impact factor: 3.452

9.  Nigella sativa relieves the deleterious effects of ischemia reperfusion injury on liver.

Authors:  Fahrettin Yildiz; Sacit Coban; Alpaslan Terzi; Mustafa Ates; Nurten Aksoy; Hale Cakir; Ali Riza Ocak; Muharrem Bitiren
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

10.  Losartan protects liver against ischaemia/reperfusion injury through PPAR-γ activation and receptor for advanced glycation end-products down-regulation.

Authors:  Eun-Ji Koh; Seong-Jin Yoon; Sun-Mee Lee
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.